yohimbine has been researched along with Sepsis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Wang, Y; Wang, Z; Zhang, J; Zhou, G | 1 |
| Chen, JH; Jin, SY; Lei, DX; Song, XR; Yu, GF; Zhang, WH; Zhou, SL | 1 |
| Li, H; Lu, D; Lv, X; Tang, X; Wang, F; Wang, H; Wang, Y; Yang, D | 1 |
| Jia, B; Li, H; Lu, D; Qi, R; Wang, D; Wang, H; Wang, Y; Yan, Y; Zhang, H | 1 |
4 other study(ies) available for yohimbine and Sepsis
| Article | Year |
|---|---|
The effect of dexmedetomidine on inflammatory response of septic rats.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Enzyme-Linked Immunosorbent Assay; Inflammation; Interleukin-6; Ligation; Male; MAP Kinase Signaling System; Myeloid Differentiation Factor 88; NF-kappa B; Random Allocation; Rats, Sprague-Dawley; Sepsis; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Yohimbine | 2015 |
Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Interleukin-1beta; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Male; Malondialdehyde; Oxidative Stress; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Sepsis; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha; Yohimbine | 2015 |
Berberine in combination with yohimbine attenuates sepsis-induced neutrophil tissue infiltration and multiorgan dysfunction partly via IL-10-mediated inhibition of CCR2 expression in neutrophils.
Topics: Animals; Antibodies, Blocking; Berberine; Cecum; Cell Movement; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Humans; Interleukin-10; Male; Mice; Mice, Inbred Strains; Multiple Organ Failure; Neutrophils; Receptors, CCR2; Sepsis; Yohimbine | 2016 |
Yohimbine enhances protection of berberine against LPS-induced mouse lethality through multiple mechanisms.
Topics: Animals; Berberine; Cells, Cultured; Drug Synergism; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mydriatics; Sepsis; Signal Transduction; Yohimbine | 2012 |